Drugs / PHP-303
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03775278 | Dec 2018 → Jul 2019 | morbid obesity | pH Pharma | Completed | No outcome recorded |
| Phase 1 | NCT03627845 | Aug → Dec 2018 | — | pH Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PHP-303 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03775278 ↗ |
| Route | Oral | “orally-administered PHP-303” NCT03627845 ↗ |